Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

InspireMD to Commence Trading as a Public Company Under Ticker Symbol “NSPR”

May 5, 2011 By Bio-Medicine.Org

TEL AVIV, Israel, May 5, 2011 /PRNewswire/ — InspireMD, Inc.
(OTC BB: NSPR) (“Inspire” or the “Company”), the developer of the
MGuard™ mesh protective stent system, announced today that it
has been approved by FINRA to have its stock quoted on the
Over-the-Counter Bulletin Board (OTCBB) under the symbol
“NSPR”.

In addition, on March 31, 2011, InspireMD concluded a $9.7
million PIPE offering in which (i) it raised approximately $9.0
million of cash and (ii) approximately $0.7 million worth of
debentures were converted. In connection with the PIPE, InspireMD
issued 6,454,002 shares of common stock and five year warrants
purchasing up to 3,226,999 shares of common stock at an exercise
price of $1.80 per share. On April 18, 2011, InspireMD raised an
additional $1,425,000, issuing 950,000 shares and 475,000
warrants.

Palladium Capital Advisors LLC, acted as the placement agent for
the capital raise and advised the company on the merger.

InspireMD, through its subsidiaries, is a high growth medical
device company focusing on the development and commercialization of
its proprietary stent platform technology: MGuard™. The
Company has created a patent-pending micron mesh technology that
wraps a stent, addressing embolic protection thereby reducing Major
Adverse Cardiac Events [MACE] by filtering debris and minimizing
vessel injury by distributing strut pressure. MGuard™ has
been implanted in thousands of patients with encouraging clinical
results in Europe and Latin America. MGuard™ is a solution
for high-risk Acute Coronary Syndrome (heart attack) patients – a
market of over two million patients per year. The Company received
CE Mark approval in Europe and has distribution agreements in more
than 30 territories, including Europe, Asia, Australia, Brazil, the
Far East, India, and South America. The Company is currently
conducting a randomized trial in Europe, Latin America and South
Africa, chaired by Dr. Gregg Stone, to sup

‘/>”/>

SOURCE

Related Articles Read More >

CeQur Simplicity
CeQur is launching a discreet, convenient ‘wearable insulin pen’
Blackrock's Utah array is a miniature array of electrodes for sensing brain signals
Blackrock Neurotech and Pitt work on first at-home BCI system for remote trials
Engineer inspecting artificial hip joint parts in quality control department in orthopaedic factory
Deburring and finishing for beautiful, functional medical devices
A Medtronic HVAD pump opened up to show the inner workings
FDA designates new Medtronic HVAD pump implant recall as Class I

DeviceTalks Weekly.

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech